Growth Metrics

Vanda Pharmaceuticals (VNDA) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -52.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -52.96%
Dec 31, 2025 -72.40%
Sep 30, 2025 -64.65%
Jun 30, 2025 -67.30%
Mar 31, 2025 -116.82%
Dec 31, 2024 -27.41%
Sep 30, 2024 -52.57%
Jun 30, 2024 -33.22%
Mar 31, 2024 -6.27%
Dec 31, 2023 -29.93%
Sep 30, 2023 -30.43%
Jun 30, 2023 -36.63%
Mar 31, 2023 233.41%
Dec 31, 2022 -1.29%
Sep 30, 2022 28.87%
Jun 30, 2022 -34.80%
Mar 31, 2022 -25.14%
Dec 31, 2021 20.35%
Sep 30, 2021 2.63%
Jun 30, 2021 63.00%
Mar 31, 2021 77.71%
Dec 31, 2020 77.25%
Sep 30, 2020 62.91%
Jun 30, 2020 132.83%
Mar 31, 2020 44.68%
Dec 31, 2019 117.41%
Sep 30, 2019 69.07%
Jun 30, 2019 102.38%
Mar 31, 2019 58.32%
Dec 31, 2018 255.36%
Sep 30, 2018 55.94%
Jun 30, 2018 -28.67%
Mar 31, 2018 -33.44%
Dec 31, 2017 31.21%
Sep 30, 2017 31.72%
Jun 30, 2017 60.50%
Mar 31, 2017 39.26%
Dec 31, 2016 54.00%
Sep 30, 2016 28.48%
Jun 30, 2016 25.98%
Mar 31, 2016 18.72%
Dec 31, 2015 70.49%
Sep 30, 2015 21.85%
Jun 30, 2015 44.08%
Mar 31, 2015 38.20%
Dec 31, 2014 -2.70%
Sep 30, 2014 -1.96%
Jun 30, 2014 -86.87%
Mar 31, 2014 -94.20%
Dec 31, 2013 -33.60%
Sep 30, 2013 -26.50%